

Cover Story
Conversation with The Cancer Letter
On Aug. 5, two months into her job as CEO of the American Cancer Society, Karen Knudsen was in Burlington, VT, checking out the Hope Lodge—the third one she visited since taking the job.
In Brief


Funding Opportunities
Clinical Roundup


Drugs & Targets


NCI Trials


NCI Trials for September 2021
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Michael Caputo appointed to President’s Cancer Panel
The cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship - The Galleri MCD vote: What FDA asked its advisors to ignore
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish















